SEC Form 4 · accession 0001209191-19-005452
Spring Bank Pharmaceuticals, Inc. · SBPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin J Driscoll
Officer — President and CEO · Director
Period of report
Jan 24, 2019
Accepted (ET)
Jan 25, 2019 · 8:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001566373
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $10.35 | Jan 24, 2019 | A | 50,000 | A | — | Jan 24, 2029 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1This option was granted on January 24, 2019, with 25% of the shares subject to the option vesting on January 24, 2020 and the remaining 75% of the shares subject to the option vesting in 36 equal monthly installments thereafter.